Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)


Open article in different language:  DE  |  FR  |  IT
Art. 86 Felonies and misdemeanours 237

1 Any per­son who wil­fully:

a.
man­u­fac­tures, places on the mar­ket, uses, pre­scribes, im­ports or ex­ports, or trades in a for­eign coun­try medi­cin­al products without the re­quired mar­ket­ing au­thor­isa­tion or li­cence, or con­trary to the due di­li­gence re­quire­ments stip­u­lated in Art­icles 3, 7, 21, 22, 26, 29 and 42;
b.
uses an­ti­bi­ot­ic sub­stances con­trary to the re­stric­tions or pro­hib­i­tions laid down in Art­icle 42apara­graph 2;
c.238
vi­ol­ates, when hand­ling blood or blood products, the ban on pay­ment for blood dona­tions, on the fit­ness of the donor to give blood, on the ob­lig­a­tion to test, on the ob­lig­a­tion to re­cord or archive or due di­li­gence re­quire­ments in ac­cord­ance with Art­icle 37, or fails to take the ne­ces­sary pro­tec­tions and safe­guards;
d.239
places on the mar­ket, ex­ports or uses med­ic­al devices which do not sat­is­fy the re­quire­ments of this Act, or uses med­ic­al devices without the ne­ces­sary tech­nic­al or op­er­a­tion­al re­quire­ments be­ing ful­filled;
e.
vi­ol­ates the due di­li­gence re­quire­ment pur­su­ant to Art­icle 48 or the ob­lig­a­tion to main­tain med­ic­al devices;
f.
per­forms a clin­ic­al tri­al on a hu­man be­ing which does not sat­is­fy the re­quire­ments of this Act, or al­lows the same to be per­formed;
g.
un­law­fully cop­ies, fals­i­fies or in­cor­rectly names medi­cin­al products or med­ic­al devices, or places on the mar­ket, uses, im­ports or ex­ports, or trades in a for­eign coun­try, un­law­fully copied, fals­i­fied or in­cor­rectly named medi­cin­al products or med­ic­al devices;
h.
vi­ol­ates a pro­hib­i­tion un­der Art­icle 55.
i.240
places on the mar­ket products which do not meet the re­quire­ments spe­cified by the Fed­er­al Coun­cil in ac­cord­ance with Art­icle 2a;
j.241
of­fers, grants, de­mands or ac­cepts a fin­an­cial gain or oth­er ad­vant­age for hu­man tis­sue or hu­man cells or uses such tis­sues or cells for the man­u­fac­ture of products as spe­cified in Art­icle 2a;
k.242
re­moves or uses hu­man tis­sue or hu­man cells for the man­u­fac­ture of products as spe­cified in Art­icle 2a in the ab­sence of con­sent for re­mov­al.
[tab]
shall be li­able to a cus­todi­al sen­tence not ex­ceed­ing three years or to a mon­et­ary pen­alty.

2 Any person who, in the cases referred to in paragraph 1 letters a–g and ik:

a.
knows or must as­sume that the vi­ol­a­tion spe­cific­ally en­dangers hu­man health;
b.
achieves a high turnover or makes sub­stan­tial profits through com­mer­cial activ­ity.

shall be li­able to a cus­todi­al sen­tence not ex­ceed­ing ten years or a mon­et­ary pen­alty.243

3 Any per­son act­ing as a mem­ber of a gang in­volved in the il­li­cit trade in thera­peut­ic products in the cases re­ferred to in para­graph 1 let­ters a, c, d, f, g and i–k shall be li­able to a cus­todi­al sen­tence not ex­ceed­ing ten years or to a mon­et­ary pen­alty.244

4 If the per­son con­cerned acts through neg­li­gence, he or she shall be li­able to a mon­et­ary pen­alty. In minor cases, a fine may be im­posed.245

237 Amended by No I of the FA of 18 March 2016 with the ex­cep­tion of para­graph 1 let­ter h in force since 1 Jan. 2020 (AS 2017 2745, 2018 3575, 2019 1393; BBl 2013 1).

238 Amended by No I of the FA of 29 Sept. 2023 (Amend­ments to the Pro­vi­sions on Blood Dona­tion), in force since 1 Jan. 2025 (AS 2024 534; BBl 2022 2348, 3169).

239 Amended by No I of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

240 In­ser­ted by No I of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

241 In­ser­ted by No I of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

242 In­ser­ted by No I of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

243 Amended by No I 30 of the FA of 17. Dec. 2021 on the Har­mon­isa­tion of Sen­ten­cing Policy, in force since 1 Ju­ly 2023 (AS 2023 259; BBl 2018 2827).

244 Amended by No I 30 of the FA of 17. Dec. 2021 on the Har­mon­isa­tion of Sen­ten­cing Policy, in force since 1 Ju­ly 2023 (AS 2023 259; BBl 2018 2827).

245 Amended by No I of the FA of 22 March 2019, in force since 26 May 2021 (AS 2020 2961; BBl 2019 1).

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden